Extrapolation of Normal Tissue Complication Probability for Different Fractionations in Liver Irradiation

International Journal of Radiation Oncology Biology Physics

Volumn 74, Issue 1, 2009, Pages 283-289

  Tai, An ^a   Erickson, Beth ^a   Li, X Allen ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Hypofractionation; Linear quadratic model; Liver irradiation; Lyman model; Radiation induced liver disease

Indexed keywords

CLINICAL DATUM; DOSE DEPENDENCES; EXTERNAL BEAM RADIATION THERAPIES; FITTING RESULTS; HYPOFRACTIONATION; LINEAR-QUADRATIC MODEL; LIVER CIRRHOSIS; LIVER TISSUES; LYMAN MODEL; MODEL PARAMETERS; NEW FORMS; NORMAL TISSUE COMPLICATION PROBABILITIES; PRIMARY LIVER CANCERS; RADIATION-INDUCED LIVER DISEASE; STEREOTACTIC BODY RADIATION THERAPIES; TOTAL DOSE; TREATMENT PLANNING; TUMOR SIZES; TWO COMPONENTS; TWO PARAMETERS;

APPROXIMATION THEORY; FRACTIONATION; IRRADIATION; RADIATION; RADIOTHERAPY; SEMICONDUCTOR DOPING;

LIVER;

ARTICLE; CANCER PATIENT; EXTERNAL BEAM RADIOTHERAPY; HUMAN; LIVER CANCER; LIVER CIRRHOSIS; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RADIATION INDUCED LIVER DISEASE; RADIATION INJURY; RADIOSENSITIVITY; SCORING SYSTEM; TREATMENT PLANNING; TUMOR VOLUME;

ALGORITHMS; CARCINOMA, HEPATOCELLULAR; CHI-SQUARE DISTRIBUTION; DOSE FRACTIONATION; HUMANS; LINEAR MODELS; LIVER; LIVER NEOPLASMS; PROBABILITY; RADIATION INJURIES; RADIATION TOLERANCE; TUMOR BURDEN;

EID: 64049108293     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2008.11.029     Document Type: Article

References (22)

1. Dawson L.A., McGinn C.J., Normolle D., et al. Escalated focal liver radiation and concurrent hepatic artery fluorodeoxyuridine for unresectable intrahepatic malignancies. J Clin Oncol 18 (2000) 2210-2218
2. Dawson L.A., Eccles C., and Craig T. Individualized image guided iso-NTCP based liver cancer SBRT. Acta Oncol 45 (2006) 856-864
3. Ben-Josef E., Normolle D., Ensminger W.D., et al. Phase II trial of high-dose conformal radiation therapy with concurrent hepatic artery floxuridine for unresectable intrahepatic malignancies. J Clin Oncol 23 (2005) 8739-8747
4. Wagman R., Yorke E., Ford E., et al. Respiratory gating for liver tumors: Use in dose escalation. Int J Radiat Oncol Biol Phys 55 (2003) 659-668
5. Dawson L.A., Normolle D., Balter J.M., et al. Analysis of radiation-induced liver disease using the Lyman NTCP model. Int J Radiat Oncol Biol Phys 53 (2002) 810-821
6. Xu Z.Y., Liang S.X., Zhu J.R.D., et al. Prediction of radiation-induced liver disease by Lyman normal-tissue complication probability model in three-dimensional conformation radiation therapy for primary liver carcinoma. Int J Radiat Oncol Biol Phys 65 (2006) 189-195
7. Cheng J.C., Wu J.K., Lee P.C., Liu H.S., et al. Biologic susceptibility of hepatocellular carcinoma patients treated with radiotherapy to radiation-induced liver disease. Int J Radiat Oncol Biol Phys 60 (2004) 1502-1509
8. Park H.C., Seong J., Han K.H., et al. Dose-response relationship in local radiotherapy for hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 54 (2002) 150-155
9. Wu D.H., Liu L., and Chen L.H. Therapeutic effects and prognostic factors in three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for hepatocellular carcinoma. World J Gastroenterol 10 (2004) 2184-2189
10. Schefter T.E., Kavanagh B.D., and Timmerman R.D. A phase I trial of stereotactic body radiation therapy (SBRT) for liver metastases. Int J Radiat Oncol Biol Phys 62 (2005) 1371-1378
11. Romero A.M., Wunderink W., Hussain S., et al. Stereotactic body radiation therapy for primary and metastatic liver tumors: A single institution phase I-II study. Acta Oncol 45 (2006) 831-837
12. Katz AW, Dawson LA, Elsaleh H, et al. A phase I trial of highly conformal radiation therapy for patients with liver metastases. Radiation Therapy Oncology Group 0438. Available at: http://www.rtog.org
13. Ten Haken R.K., and Dawson L.A. Prediction of radiation-induced liver disease by Lyman normal-tissue complication probability model in three-dimensional conformal radiation therapy for primary liver carcinoma: In regards to Xu, et al. Int J Radiat Oncol Biol Phys 66 (2006) 1272-1272
14. Jiang G.L. In response to Dr. Ten Haken, et al. Int J Radiat Oncol Biol Phys 66 (2006) 1272-1273
15. Lyman J.T. Normal tissue complication probabilities: Variable dose per fraction. Int J Radiat Oncol Biol Phys 22 (1992) 247-250
16. Tai A., Erickson B., Khater K., and Li X.A. Estimate of radiobiological parameters from clinical data for biologically based treatment planning for liver irradiation. Int J Radiat Oncol Biol Phys 70 (2008) 900-907
17. Dawson L.A., and Ten Haken R.K. Partial volume tolerance of the liver to radiation. Semin Radiat Oncol 15 (2005) 279-283
18. Jackson A., Ten Haken R.K., Robertson J.M., et al. Analysis of clinical complication data for radiation hepatitis using a parallel architecture model. Int J Radiat Oncol Biol Phys 31 (1995) 883-891
19. Dawson L.A., Ten Haken R.K., and Lawrence T.S. Partial irradiation of the liver. Semin Radiat Oncol 11 (2001) 240-246
20. Liang S.X., Zhu X.D., Xu Z.Y., et al. Radiation-induced liver disease in three-dimensional conformal radiation therapy for primary liver carcinoma: The risk factors and hepatic radiation tolerance. Int J Radiat Oncol Biol Phys 65 (2006) 426-434
21. th ed. (2006), Lippincott Williams & Wilkins, Philadelphia p. 68
22. Fausto N. Liver regeneration. J Hepatol 32 (2000) 19-31